-
1
-
-
10744225818
-
Front-line treatment of inoperable or metastatic pancreatic cancer with gemcitabine and capecitabine: An intergroup, multicenter, phase II study
-
Stathopoulos GP, Syrigos K, Polyzos A, et al. Front-line treatment of inoperable or metastatic pancreatic cancer with gemcitabine and capecitabine: an intergroup, multicenter, phase II study. Ann Oncol 2004;15:224-229.
-
(2004)
Ann Oncol
, vol.15
, pp. 224-229
-
-
Stathopoulos, G.P.1
Syrigos, K.2
Polyzos, A.3
-
2
-
-
18844453135
-
Surgery for pancreatic cancer: Recent controversies and current practice
-
Wray CJ, Ahmad SA, Matthews JB, et al. Surgery for pancreatic cancer: recent controversies and current practice. Gastroenterology. 2005;128:1626-1641.
-
(2005)
Gastroenterology
, vol.128
, pp. 1626-1641
-
-
Wray, C.J.1
Ahmad, S.A.2
Matthews, J.B.3
-
3
-
-
0027182442
-
Diagnosis and staging of pancreatic adenocarcinoma with dynamic computed tomography
-
Freeny PC, Traverso LW, Ryan JA. Diagnosis and staging of pancreatic adenocarcinoma with dynamic computed tomography. Am J Surg 1993;165:600-606.
-
(1993)
Am J Surg
, vol.165
, pp. 600-606
-
-
Freeny, P.C.1
Traverso, L.W.2
Ryan, J.A.3
-
4
-
-
0033036104
-
Patients with laparoscopically staged unresectable pancreatic adenocarcinoma do not require subsequent surgical biliary or gastric bypass
-
Espat NJ, Brennan MF, Conlon KC. Patients with laparoscopically staged unresectable pancreatic adenocarcinoma do not require subsequent surgical biliary or gastric bypass. J Am Coll Surg 1999;188:649-655.
-
(1999)
J Am Coll Surg
, vol.188
, pp. 649-655
-
-
Espat, N.J.1
Brennan, M.F.2
Conlon, K.C.3
-
5
-
-
0029816521
-
Isolated portal vein involvement in pancreatic adenocarcinoma. A contraindication for resection?
-
Harrison LE, Klimstra DS, Brennan MF. Isolated portal vein involvement in pancreatic adenocarcinoma. A contraindication for resection? Ann Surg 1996;224:342-47; discussion 347-349.
-
(1996)
Ann Surg
, vol.224
, pp. 342-347
-
-
Harrison, L.E.1
Klimstra, D.S.2
Brennan, M.F.3
-
6
-
-
10044289594
-
Pancreaticoduodenectomy with vascular resection: Margin status and survival duration
-
Tseng JF, Raut CP, Lee JE, et al. Pancreaticoduodenectomy with vascular resection: margin status and survival duration. J Gastrointest Surg 2004;8:935-949.
-
(2004)
J Gastrointest Surg
, vol.8
, pp. 935-949
-
-
Tseng, J.F.1
Raut, C.P.2
Lee, J.E.3
-
7
-
-
27544500200
-
A prospective randomized trial comparing standard pancreatoduodenectomy with pancreatoduodenectomy with extended lymphadenectomy in resectable pancreatic head adenocarcinoma
-
Farnell MB, Pearson RK, Sarr MG. and the Pancreas Cancer Working Goup. A prospective randomized trial comparing standard pancreatoduodenectomy with pancreatoduodenectomy with extended lymphadenectomy in resectable pancreatic head adenocarcinoma. Surgery 2005;138:618-628; discussion 628-630.
-
(2005)
Surgery
, vol.138
, pp. 618-628
-
-
Farnell, M.B.1
Pearson, R.K.2
Sarr, M.G.3
-
8
-
-
27544500200
-
A prospective randomized trial comparing standard pancreatoduodenectomy with pancreatoduodenectomy with extended lymphadenectomy in resectable pancreatic head adenocarcinoma
-
Farnell MB, Pearson RK, Sarr MG, et al. and the Pancreas Cancer Working Group. A prospective randomized trial comparing standard pancreatoduodenectomy with pancreatoduodenectomy with extended lymphadenectomy in resectable pancreatic head adenocarcinoma. Surgery 2005;138:618-628.
-
(2005)
Surgery
, vol.138
, pp. 618-628
-
-
Farnell, M.B.1
Pearson, R.K.2
Sarr, M.G.3
|